Point of Care Diagnostics Market Overview, Global Size | 2026-2034

Table of Contents

Chapter 1.    Introduction
1.1    Report Description
1.1.1    Objectives of the Study
1.2    Market segmentation& scope
1.2.1    Assumptions
1.2.2    Stakeholders
Chapter 2.    Executive Summary
2.1    Market Highlights
Chapter 3.    Research Methodology
3.1    Overview
3.1.1    Data Mining
3.2    Data Sources
3.2.1    Primary Sources
3.2.2    Secondary Sources
Chapter 4.    Point of Care (PoC) Diagnostics Market Insights
4.1    Point of Care (PoC) Diagnostics – Industry snapshot
4.2    Point of Care (PoC) Diagnostics Market Dynamics
4.2.1    Market Driver Analysis
4.2.1.1    Introduction of CLIA waived tests
4.2.1.2    Growing Prevalence of Chronic and Infectious Diseases
4.2.1.3    Rising Advancement in PoC Technology
4.2.1.4    Growing geriatric population base
4.2.1.5    Growing prevalence of target diseases
4.2.1.6    Widespread adoption of RT-PCR Covid-19 testing and point-of care testing
4.2.1.7    Advent of New Technology
4.2.1.8    Growing demand for home healthcare and advent of advanced technology enabled products
4.2.2    Market Restraint Analysis
4.2.2.1    High procedure costs
4.2.2.2    Presence of ambiguous regulatory framework
4.3    Porter’s Five Forces Analysis
4.4    Point-of-Care Diagnostics– SWOT Analysis, By Factor (political & legal, economic and technological)
4.5    Competitive Landscape: Major market participants
4.5.1    Company size
4.5.2    Distribution network
4.5.3    Product portfolio
4.5.4    Segment coverage
4.5.5    Geographic presence
4.5.6    Collaborations
4.5.7    Conclusion
4.6    Product Positioning Analysis
4.6.1    Glucose testing
4.6.2    Hb1Ac testing
4.6.3    Coagulation testing
4.6.4    Fertility POC
4.6.5    Cardiac markers POC
4.6.6    Infectious disease POC diagnostics
4.6.7    Other point-of-care product segments
4.7    Marketing Channels
4.7.1    Abbott Diagnostics
4.7.1.1    Marketing Channels & Distribution Network
4.7.2    Roche Diagnostics
4.7.2.1    Marketing Channels & Distribution Network
4.7.3    Alere Inc.
4.7.3.1    Marketing Channels & Distribution Network
4.7.4    Siemens Healthcare
4.7.4.1    Marketing Channels & Distribution Network
4.7.5    Danaher Corporation
4.7.5.1    Marketing Channels & Distribution Network
4.7.6    Instrumentation Laboratory Spa.
4.7.6.1    Marketing Channels & Distribution Network
4.8    Point of Care (PoC) Diagnostics Market Industry trends
Chapter 5.    Point of Care (PoC) Diagnostics Market Assessment by Product
5.1    Introduction
5.1    Glucose Testing
5.2    Hb1Ac Testing
5.3    Coagulation
5.4    Fertility
5.5    Cardiac Markers
5.6    Infectious Diseases
5.7    Primary Care Systems (Includes Lipid)
5.8    Hematology
5.9    Decentralized Clinical Chemistry
5.10    Feces
5.11    Blood Gas/Electrolytes
5.12    Ambulatory Chemistry
5.13    Urinalysis
5.14    Drug Abuse Testing
Chapter 6.    Point of Care (PoC) Diagnostics Market Assessment by Infectious Diseases
6.1    Introduction
6.2    HIV POC
6.3    Clostridium difficile POC
6.4    HBV POC
6.5    Pneumonia or Streptococcus associated infections
6.6    Respiratory syncytial virus (RSV) POC
6.7    HPV POC
6.8    Influenza/Flu POC
6.9    HCV POC
6.10    MRSA POC
6.11    TB & drug-resistant TB POC
6.12    HSV POC
6.13    Other Infectious Diseases
Chapter 7.    Point of Care (PoC) Diagnostics Market Assessment by End-Use
7.1    Introduction
7.2    Clinics
7.3    Hospitals
7.4    Home
7.5    Assisted Living Healthcare Facilities
7.6    Laboratory
7.7    Other End-Uses
Chapter 8.    Point of Care (PoC) Diagnostics Market Assessment by Mode of Prescription
8.1    Introduction
8.2    OTC
8.3    Prescription-based
Chapter 9.    Point of Care (PoC) Diagnostics Market Assessment by Region
9.1    Introduction
9.2    Point of Care (PoC) Diagnostics Market – North America
9.2.1    Point of Care (PoC) Diagnostics Market – U.S.
9.2.2    Point of Care (PoC) Diagnostics Market – Canada
9.3    Point of Care (PoC) Diagnostics Market – Europe
9.3.1    Point of Care (PoC) Diagnostics Market – Germany
9.3.2    Point of Care (PoC) Diagnostics Market – France
9.3.3    Point of Care (PoC) Diagnostics Market – UK
9.3.4    Point of Care (PoC) Diagnostics Market – Italy
9.3.5    Point of Care (PoC) Diagnostics Market – Spain
9.4    Point of Care (PoC) Diagnostics Market – Asia Pacific
9.4.1    Point of Care (PoC) Diagnostics Market – Japan
9.4.2    Point of Care (PoC) Diagnostics Market – China
9.4.3    Point of Care (PoC) Diagnostics Market – India
9.4.4    Point of Care (PoC) Diagnostics Market – South Korea
9.4.5    Point of Care (PoC) Diagnostics Market – Singapore
9.4.6    Point of Care (PoC) Diagnostics Market – Australia
9.5    Point of Care (PoC) Diagnostics Market – Latin America
9.5.1    Point of Care (PoC) Diagnostics Market – Brazil
9.5.2    Point of Care (PoC) Diagnostics Market – Mexico
9.5.3    Point of Care (PoC) Diagnostics Market – Chile
9.5.4    Point of Care (PoC) Diagnostics Market – Argentina
9.6    Point of Care (PoC) Diagnostics Market – Middle East & Africa
9.6.1    Point of Care (PoC) Diagnostics Market – Saudi Arabia
9.6.2    Point of Care (PoC) Diagnostics Market – UAE
9.6.3    Point of Care (PoC) Diagnostics Market – South Africa
9.6.4    Point of Care (PoC) Diagnostics Market – Nigeria
9.6.5    Point of Care (PoC) Diagnostics Market – Qatar
9.6.6    Point of Care (PoC) Diagnostics Market – Kenya
9.6.7    Point of Care (PoC) Diagnostics Market – Zimbabwe
Chapter 10.    Competitive Landscape
10.1    Product Launch and Acquisition Are the Best Adopted Strategy by the Companies
10.2    Expansion
10.3    Product Launch
10.4    Partnerships/Collaborations/Agreements/Exhibitions
Chapter 11.    Company Profiles
11.1     Abbott
11.1.1    Business Overview
11.1.2    Financial Snapshot
11.1.3    Products and Services
11.1.4    Recent Developments
11.2    BD
11.2.1    Business Overview
11.2.2    Financial Snapshot
11.2.3    Products and Services
11.2.4    Recent Developments
11.3    bioMérieux
11.3.1    Business Overview
11.3.2    Financial Snapshot
11.3.3    Products and Services
11.3.4    Recent Developments
11.4    Danaher Corporation
11.4.1    Business Overview
11.4.2    Financial Snapshot
11.4.3    Products and Services
11.4.4    Recent Developments
11.5    EKF Diagnostics Holdings plc
11.5.1    Business Overview
11.5.2    Financial Snapshot
11.5.3    Products and Services
11.5.4    Recent Developments
11.6    F. Hoffmann-La Roche Ltd
11.6.1    Business Overview
11.6.2    Financial Snapshot
11.6.3    Products and Services
11.6.4    Recent Developments
11.7    Quest Diagnostics Incorporated
11.7.1    Business Overview
11.7.2    Financial Snapshot
11.7.3    Products and Services
11.7.4    Recent Developments
11.8    QuidelOrtho Corporation
11.8.1    Business Overview
11.8.2    Financial Snapshot (Abbott Lab.)
11.8.3    Products and Services
11.8.4    Recent Developments
11.9    Siemens Healthcare Private Limited
11.9.1    Business Overview
11.9.2    Financial Snapshot
11.9.3    Products and Services
11.9.4    Recent Developments
11.10    Thermo Fisher Scientific Inc
11.10.1    Business Overview
11.10.2    Financial Snapshot
11.10.3    Products and Services
11.10.4    Recent Developments
11.11    Nova Biomedical
11.11.1    Business Overview
11.11.2    Products and Services
11.11.3    Recent Developments
11.12    HemoCue AB
11.12.1    Business Overview
11.12.2    Financial Snapshot
11.12.3    Products and Services
11.13    International Technidyne Corporation (ITC)
11.13.1    Business Overview
11.13.2    Products and Services
11.14    Quidel Corporation
11.14.1    Business Overview
11.14.2    Financial Snapshot
11.14.3    Products and Services
11.15    Trinity Biotech PLC
11.15.1    Business Overview
11.15.2    Financial Snapshot
11.15.3    Products and Services
11.16    Sekisui Diagnostics LLC
11.16.1    Business Overview
11.16.2    Financial Snapshot
11.16.3    Products and Services
11.16.4    Recent Developments
11.17    OraSure Technologies Inc.
11.17.1    Business Overview
11.17.2    Financial Snapshot
11.17.3    Products and Services
11.17.4    Recent Developments
11.18    Spectral Diagnostics
11.18.1    Business Overview
11.18.2    Financial Snapshot
11.18.3    Products and Servicesovid
11.18.4    Recent Developments
11.19    PTS Diagnostics
11.19.1    Business Overview
11.19.2    Products and Services

List of Tables
Table 1    Examples: CLIA waived tests
Table 2    Point of care solutions, by segment
Table 3    North America diabetes prevalence (national prevalence %), 2021 & 2034
Table 4    Europe diabetes prevalence (national prevalence %), 2021 & 2034
Table 5    Asia Pacific diabetes prevalence (national prevalence %), 2021 & 2034
Table 6    Latin America Diabetes Prevalence (national prevalence %), 2021 & 2034
Table 7    MEA diabetes prevalence (national prevalence %), 2021 & 2034
Table 8    CIS diabetes prevalence (national prevalence %), 2021 & 2034
Table 9    Abbott Healthcare: List of Wholesalers & Distributors
Table 10    Global Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 1    Global Point of Care (PoC) Diagnostics Market, by Glucose Testing, 2021 – 2034 (USD Billion)
Table 2    Global Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, 2021 – 2034 (USD Billion)
Table 3    Global Point of Care (PoC) Diagnostics Market, by Coagulation, 2021 – 2034 (USD Billion)
Table 4    Global Point of Care (PoC) Diagnostics Market, by Fertility, 2021 – 2034 (USD Billion)
Table 5    Global Point of Care (PoC) Diagnostics Market, by Cardiac Markers, 2021 – 2034 (USD Billion)
Table 6    Global Point of Care (PoC) Diagnostics Market, by Infectious Diseases, 2021 – 2034 (USD Billion)
Table 7    Global Point of Care (PoC) Diagnostics Market, by Primary Care Systems (Includes Lipid), 2021 – 2034 (USD Billion)
Table 8    Global Point of Care (PoC) Diagnostics Market, by Hematology, 2021 – 2034 (USD Billion)
Table 9    Global Point of Care (PoC) Diagnostics Market, by Decentralized Clinical Chemistry, 2021 – 2034 (USD Billion)
Table 10    Global Point of Care (PoC) Diagnostics Market, by Feces, 2021 – 2034 (USD Billion)
Table 11    Global Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, 2021 – 2034 (USD Billion)
Table 12    Global Point of Care (PoC) Diagnostics Market, by Ambulatory Chemistry, 2021 – 2034 (USD Billion)
Table 13    Global Point of Care (PoC) Diagnostics Market, by Urinalysis, 2021 – 2034 (USD Billion)
Table 14    Global Point of Care (PoC) Diagnostics Market, by Drug Abuse Testing, 2021 – 2034 (USD Billion)
Table 15    Global Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 16    Global Point of Care (PoC) Diagnostics Market, by HIV POC, 2021 – 2034 (USD Billion)
Table 17    Global Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, 2021 – 2034 (USD Billion)
Table 18    Global Point of Care (PoC) Diagnostics Market, by HBV POC, 2021 – 2034 (USD Billion)
Table 19    Global Point of Care (PoC) Diagnostics Market, by Pneumonia or Streptococcus associated infections, 2021 – 2034 (USD Billion)
Table 20    Global Point of Care (PoC) Diagnostics Market, by Respiratory syncytial virus (RSV) POC, 2021 – 2034 (USD Billion)
Table 21    Global Point of Care (PoC) Diagnostics Market, by HPV POC, 2021 – 2034 (USD Billion)
Table 22    Global Point of Care (PoC) Diagnostics Market, by Influenza/Flu POC, 2021 – 2034 (USD Billion)
Table 23    Global Point of Care (PoC) Diagnostics Market, by HCV POC, 2021 – 2034 (USD Billion)
Table 24    Global Point of Care (PoC) Diagnostics Market, by MRSA POC, 2021 – 2034 (USD Billion)
Table 25    Global Point of Care (PoC) Diagnostics Market, by TB & drug-resistant TB POC, 2021 – 2034 (USD Billion)
Table 26    Global Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, 2021 – 2034 (USD Billion)
Table 27    Global Point of Care (PoC) Diagnostics Market, by Other Infectious Diseases, 2021 – 2034 (USD Billion)
Table 28    Global Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 29    Global Point of Care (PoC) Diagnostics Market, by Clinics, 2021 – 2034 (USD Billion)
Table 30    Global Point of Care (PoC) Diagnostics Market, by Hospitals, 2021 – 2034 (USD Billion)
Table 31    Global Point of Care (PoC) Diagnostics Market, by Home, 2021 – 2034 (USD Billion)
Table 32    Global Point of Care (PoC) Diagnostics Market, by Assisted Living Healthcare Facilities, 2021 – 2034 (USD Billion)
Table 33    Global Point of Care (PoC) Diagnostics Market, by Laboratory, 2021 – 2034 (USD Billion)
Table 34    Global Point of Care (PoC) Diagnostics Market, by Other End-Uses, 2021 – 2034 (USD Billion)
Table 35    Global Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 36    Global Point of Care (PoC) Diagnostics Market, by OTC, 2021 – 2034 (USD Billion)
Table 37    Global Point of Care (PoC) Diagnostics Market, by Prescription-based, 2021 – 2034 (USD Billion)
Table 38    Point of Care (PoC) Diagnostics Market Assessment, By Geography, 2021 – 2034 (USD Billion)
Table 39    North America Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 40    North America Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 41    North America Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 42    North America Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 43    U.S. Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 44    U.S. Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 45    U.S. Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 46    U.S. Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 47    Canada Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 48    Canada Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 49    Canada Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 50    Canada Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 51    Europe Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 52    Europe Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 53    Europe Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 54    Europe Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 55    Germany Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 56    Germany Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 57    Germany Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 58    Germany Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 59    France Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 60    France Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 61    France Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 62    France Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 63    UK Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 64    UK Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 65    UK Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 66    UK Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 67    Italy Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 68    Italy Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 69    Italy Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 70    Italy Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 71    Spain Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 72    Spain Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 73    Spain Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 74    Spain Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 75    Asia Pacific Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 76    Asia Pacific Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 77    Asia Pacific Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 78    Asia Pacific Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 79    Japan Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 80    Japan Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 81    Japan Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 82    Japan Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 83    China Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 84    China Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 85    China Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 86    China Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 87    India Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 88    India Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 89    India Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 90    India Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 91    South Korea Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 92    South Korea Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 93    South Korea Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 94    South Korea Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 95    Singapore Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 96    Singapore Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 97    Singapore Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 98    Singapore Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 99    Australia Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 100    Australia Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 101    Australia Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 102    Australia Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 103    Latin America Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 104    Latin America Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 105    Latin America Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 106    Latin America Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 107    Brazil Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 108    Brazil Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 109    Brazil Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 110    Brazil Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 111    Mexico Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 112    Mexico Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 113    Mexico Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 114    Mexico Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 115    Chile Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 116    Chile Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 117    Chile Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 118    Chile Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 119    Argentina Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 120    Argentina Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 121    Argentina Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 122    Argentina Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 123    Middle East & Africa Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 124    Middle East & Africa Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 125    Middle East & Africa Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 126    Middle East & Africa Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 127    Saudi Arabia Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 128    Saudi Arabia Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 129    Saudi Arabia Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 130    Saudi Arabia Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 131    UAE Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 132    UAE Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 133    UAE Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 134    UAE Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 135    South Africa Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 136    South Africa Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 137    South Africa Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 138    South Africa Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 139    Nigeria Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 140    Nigeria Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 141    Nigeria Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 142    Nigeria Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 143    Qatar Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 144    Qatar Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 145    Qatar Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 146    Qatar Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 147    Kenya Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 148    Kenya Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 149    Kenya Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 150    Kenya Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)
Table 151    Zimbabwe Point of Care (PoC) Diagnostics Market, By Product, 2021 – 2034 (USD Billion)
Table 152    Zimbabwe Point of Care (PoC) Diagnostics Market, By Infectious Diseases, 2021 – 2034 (USD Billion)
Table 153    Zimbabwe Point of Care (PoC) Diagnostics Market, By End-Use, 2021 – 2034 (USD Billion)
Table 154    Zimbabwe Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2021 – 2034 (USD Billion)

List of Figures
Figure 1.    Market Highlights
Figure 2.    Integrated Ecosystem
Figure 3.    Market by Geography, 2020 - 2028 (USD Billion)
Figure 4.    Market trends and outlook
Figure 5.    Market driver relevance analysis (Current & future impact)
Figure 6.    Shift in POC molecular diagnostic trends
Figure 7.    Global percentage of population, by age group, 2000 and 2050
Figure 8.    Population over the age of 65 years, by region, 2010 and 2050
Figure 9.    Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (Billion)
Figure 10.    Current and projected prevalence of diabetes, by geography, 2021 & 2034 (% increase)
Figure 11.    Market restraint relevance analysis (Current & future impact)
Figure 12.    Porter’s Five Forces
Figure 13.    SWOT Analysis, By Factor (political & legal, economic, and technological)
Figure 14.    Competitive Landscape POC Diagnostics – Major market participants
Figure 15.    POC diagnostics – product segments positioning, 2021
Figure 16.    Marketing Channels
Figure 17.    Roche Distribution Presence
Figure 18.    Instrumentation Laboratory (Werfen Group) Distribution Presence
Figure 19.    Abbott Laboratories Distribution Network Coverage
Figure 20.    Alere Distribution Presence
Figure 21.    Siemens Healthcare Distribution Presence
Figure 22.    Danaher Distribution Presence (Radiometer and Beckman Coulter)
Figure 23.    Point of Care (PoC) Diagnostics Market Assessment, By Geography (USD Billion)
Figure 24.    Strategic Analysis – Point of Care Diagnostics Market